VivoSim Labs, INC. — Director's Dealing 2016

Aug 10, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORGANOVO HOLDINGS, INC. (ONVO)
CIK: 0001497253
Period of Report: 2016-08-05

Reporting Person: David Eric (CSO & EVP Pre-Clinical Dev)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-08-05	Common Stock	S	20000	$4.55	Disposed	706306	Direct

Footnotes

F1: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2: This number does not include 1,070,000 shares of common stock underlying outstanding options held by Dr. David; post-transaction Dr. David beneficially owns or has a right to acquire 1,776,306 shares of common stock.